ArticleFrontiers in public health2025
Strategies for harm reduction in Latin America: the example of tobacco.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tobacco consumption continues to impose a profound public health and economic burden across Latin America, disproportionately affecting men, adolescents, and low-income populations. Despite progress in some countries through implementation of the World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC), significant gaps remain due to weak regulatory frameworks, limited enforcement capacity, and persistent interference from the tobacco industry. Against this backdrop, tobacco harm reduction (THR), the substitution of combustible products with non-combustible or lower-exposure alternatives such as nicotine replacement therapies, electronic cigarettes, and heated tobacco products, offers a potentially valuable but underutilized strategy. Rather than a systematic review, this work offers a narrative, opinion-based synthesis of policy and evidence sources published between 2015 and 2024. While the WHO currently does not endorse electronic cigarettes or heated-tobacco products as cessation tools, the guiding principles of the WHO FCTC: proportional risk assessment, transparency, and surveillance, provide a conceptual basis for evaluating all nicotine-delivery systems under strict regulation. Latin-American governments should prioritize access to approved nicotine-replacement therapies and cessation services, while considering time-bounded, independent evaluation of non-combustible products within WHO FCTC guardrails where these are already present in the market. This perspective aims to inform balanced, evidence-based debate rather than advocate adoption of any specific product or policy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.